You can buy or sell LivaNova and other stocks, options, ETFs, and crypto commission-free!
LivaNova PLC Ordinary Shares, also called LivaNova, is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. Read More The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on October 19, 2015 and is headquartered in London, the United Kingdom.
London, Greater London
52 Week High
52 Week Low
Present Fundamentals: LivaNova (NASDAQ: LIVN)
LivaNova is part of the healthcare sector and is in the medical devices industry. The company CEO is Damien McDonald. LivaNova is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics, a medical device company with core expertise in neuromodulation. Previous Intraday Trading Performance: The LIVN stock showed a previous change of -3.82% with an open at 73.97 and a close of 72.09. It reached an intraday high of 74.92 and a low ...
Seeking AlphaMay 5
LivaNova PLC (LIVN) CEO Damien McDonald on Q1 2019 Results - Earnings Call Transcript
LivaNova PLC (NASDAQ:LIVN) Q1 2019 Results Earnings Conference Call May 1, 2019 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice President of Investor Relations Conference Call Participants Raj Denhoy - Jefferies LLC Rick Wise - Stifel Matthew O'Brien - Piper Jaffray Scott Bardo - Berenberg Matthew Taylor - UBS Michael Matson - Needham & Company, LLC ...
Markets InsiderMay 3
New Data Emphasizing LivaNova Perceval Valve Durability to be Presented at the American Association for Thoracic Surgery Meeting
Livanova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that new clinical data for its sutureless surgical aortic valve, Perceval®, will be unveiled at this year’s American Association for Thoracic Surgery (AATS) meeting.
Expected Jul 31, Pre-Market